SOURCE: VisiJet, Inc.

June 28, 2005 09:00 ET

VisiJet, Inc. Schedules Additional Shareholder Meeting on June 30, 2005, at Company Headquarters in San Clemente

SAN CLEMENTE, CA -- (MARKET WIRE) -- June 28, 2005 -- VisiJet Inc. (OTC BB: VJET), dba Advanced Refractive Technologies, announced today that it has scheduled an additional shareholder meeting, which will serve as a quorum for its recently approved proxy concerning the Board of Directors, to be held Thursday, June 30, 2005, at the Company's Headquarters in San Clemente. Interested investors are encouraged to come down to the Advanced Refractive Technologies building at 10 a.m. PDT to participate.

Thursday's quorum will also be an opportunity for shareholders to visit the Company's operations headquarters, learn more about the revolutionary EpiLift system and its anticipated impact on the LASIK and refractive surgical markets, participate in a question and answer session with CEO Randal Bailey and give feedback concerning VisiJet's plans to revitalize its market awareness and market capitalization.

Advanced Refractive Technologies is located in San Clemente, CA, off East Avenida Pico, at 1062 Calle Negocio, Suite D. CEO Randal Bailey can be contacted through the Company's main line: (949) 940-1300. Questions regarding the scheduled quorum should be directed to Andy Arms of Equitilink LLC, toll-free (877) 788-1940.

About VisiJet, Inc. (dba) Advanced Refractive Technologies:

VisiJet Inc., which does business as Advanced Refractive Technologies, is a medical device company based in Southern California that is focused on the development and marketing of innovative ophthalmic applications. The company recently received FDA approval for its EpiLift system, a next-generation, ophthalmic surgical device designed for separating corneal tissue. The EpiLift system is the cornerstone of a new improvement in LASIK surgery called Epi-LASIK. The EpiLift system improves upon existing technologies using a unique separating method that eliminates many postoperative problems. VisiJet holds a license from Gebauer Medizintechnik GmbH, a German engineering firm, which developed and manufactures the EpiLift System.

In addition to the EpiLift system, Advanced Refractive Technologies is currently developing a system for cataract surgery known as Pulsatome®. The Pulsatome® cataract emulsifier is a device that utilizes the company's proprietary and patented waterjet technology to remove cataracts -- the most frequently performed surgical procedure in the world. Both the EpiLift and Pulsatome systems are designed to help surgeons provide faster, safer and more efficacious procedures in what are two of the largest surgical markets in the world: refractive and cataract surgeries.

For additional information please visit: www.visijet.com

This release contains forward-looking statements that reflect the company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein and depend on a number of factors including, but not limited to, changing market conditions, successful and timely completion of clinical studies, uncertainties related to the regulatory approval process, establishment of corporate alliances and other risks detailed from time to time in the company's quarterly, annual and other regular filings.

Contact Information

  • Contact:

    Advanced Refractive Technologies
    Norman Schwartz
    912-638-6740 ext. 326
    or
    Equitilink LLC
    Investor Relations
    877-788-1940 toll-free
    858-824-1940 local or intl.
    Email Contact